Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway
| Autor: | Luan, Wenkang, Lu, Xu, Peng, Huiyong, Shen, Xuanlin, Rao, Min, Ruan, Hongru |
|---|---|
| Zdroj: | In Pathology - Research and Practice August 2024 260 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect